IMNM Jul 2024 25.000 put
| Previous Close | 11.70 |
| Open | 11.70 |
| Bid | 9.50 |
| Ask | 11.10 |
| Strike | 25.00 |
| Expire Date | 2024-07-19 |
| Day's Range | 11.70 - 11.70 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 36 |
Business WireImmunome to Present at 2024 Bank of America Healthcare Conference
BOTHELL, Wash., May 08, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and Chief Executive Officer, will present at the 2024 Bank of America Healthcare Conference on Wednesday, May 15, 2024 at 10:40 A.M. Pacific Time.
Business WireImmunome Appoints Kinney Horn as Chief Business Officer
BOTHELL, Wash., May 02, 2024--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Kinney Horn as Chief Business Officer. Mr. Horn brings to Immunome extensive experience across life sciences corporate and business development, alliance management, and commercial strategy.
ZacksAnalysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
Immunome (IMNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
